Pub Date : 2024-07-04DOI: 10.2174/0115734048286695240627060120
L. Pourali, A. Vatanchi, H. Majd, N. Ghomian, Solaleh Jabarzadeh
Methotrexate (MTX) was traditionally administered using the multi-dose regimen or single-dose protocols to treat ectopic pregnancies. The two-dose regimen was described as a cross between these two previous protocols aiming to lower side effects than multi-dose with a higher success rate of single-dose protocols. Hence, this study compared double-dose versus singledose methotrexate therapy in the treatment of ectopic pregnancy. This prospective cohort study was performed on the women referred to the academic hospitals of Mashhad University of Medical Sciences from March 2018 to July 2021 who were diagnosed as having stable tubal ectopic pregnancy and selected for medical treatment with methotrexate. Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) software (version 26). P≤0.05 was considered a significant level. A total number of 347 patients were included in this study. About 300 cases were evaluated: 240 cases in single-dose and 60 cases in the double-dose group. The Beta Human chorionic gonadotropin (Beta-hCG) declined more than 15% between days 4 and 7 and was significantly higher in the double-dose group (P<0.001). Regarding the time from MTX administration until Beta- hCG level <5mIU/mg, this time was significantly shorter in the double-dose group (P=0.045). Considering the side effects, there was no complication in any of the groups. However, tubal rupture was seen in 17 cases of double-dose and 10 cases in the single-dose group, respectively. The results of the current study showed a higher treatment success rate in double-dose MTX protocol with comparable side effects compared to single-dose MTX protocol for the treatment of stable tubal ectopic pregnancy.
{"title":"Double-dose Versus Single-dose Methotrexate Therapy in Treatment of Ectopic Pregnancy","authors":"L. Pourali, A. Vatanchi, H. Majd, N. Ghomian, Solaleh Jabarzadeh","doi":"10.2174/0115734048286695240627060120","DOIUrl":"https://doi.org/10.2174/0115734048286695240627060120","url":null,"abstract":"\u0000\u0000Methotrexate (MTX) was traditionally administered using the multi-dose\u0000regimen or single-dose protocols to treat ectopic pregnancies. The two-dose regimen was described\u0000as a cross between these two previous protocols aiming to lower side effects than multi-dose with a\u0000higher success rate of single-dose protocols. Hence, this study compared double-dose versus singledose\u0000methotrexate therapy in the treatment of ectopic pregnancy.\u0000\u0000\u0000\u0000This prospective cohort study was performed on the women referred to the academic\u0000hospitals of Mashhad University of Medical Sciences from March 2018 to July 2021 who were diagnosed\u0000as having stable tubal ectopic pregnancy and selected for medical treatment with methotrexate.\u0000Statistical analysis was performed using the Statistical Package for the Social Sciences\u0000(SPSS) software (version 26). P≤0.05 was considered a significant level.\u0000\u0000\u0000\u0000A total number of 347 patients were included in this study. About 300 cases were evaluated:\u0000240 cases in single-dose and 60 cases in the double-dose group. The Beta Human chorionic\u0000gonadotropin (Beta-hCG) declined more than 15% between days 4 and 7 and was significantly\u0000higher in the double-dose group (P<0.001). Regarding the time from MTX administration until Beta-\u0000hCG level <5mIU/mg, this time was significantly shorter in the double-dose group (P=0.045).\u0000Considering the side effects, there was no complication in any of the groups. However, tubal rupture\u0000was seen in 17 cases of double-dose and 10 cases in the single-dose group, respectively.\u0000\u0000\u0000\u0000The results of the current study showed a higher treatment success rate in double-dose\u0000MTX protocol with comparable side effects compared to single-dose MTX protocol for the treatment\u0000of stable tubal ectopic pregnancy.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141677731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-16DOI: 10.2174/0115734048287230240429171400
N. Radnia, E. Talebi-Ghane, Heydar Tavilani, Maryam Garousian, Neda Alimohammadi, Marzieh Ghorbani
The data indicated that out of 114175 deliveries, there were 60 hysterectomies over 14 years with the age range of 20-45 years. The incidence of hysterectomy increased from 0.34/1000 during 2009-2015 to 0.71/1000 deliveries in 2015-2022, with an overall incidence of 0.53 per 1000 deliveries during 14 years. The results indicated that the mean rate of hysterectomy (0.95% CI) increased significantly by 0.059 yearly, and by adjusting other variables, the history of CS (0.95% CI) and placenta accreta previa significantly increased the hysterectomy mean rate by 0.291 (0.053- 0.529) and 0.284 (0.074-0.494), respectively. The mean rate of hysterectomy represented an annual increase, especially during the last 7 years. In summary, the main reason can be the history of CS that leads to placental disorders and, thus, hysterectomy.
{"title":"The Trend of Cesarean Hysterectomy in Hamadan, Iran, between 2009-2022","authors":"N. Radnia, E. Talebi-Ghane, Heydar Tavilani, Maryam Garousian, Neda Alimohammadi, Marzieh Ghorbani","doi":"10.2174/0115734048287230240429171400","DOIUrl":"https://doi.org/10.2174/0115734048287230240429171400","url":null,"abstract":"\u0000\u0000The data indicated that out of 114175 deliveries, there were 60 hysterectomies over 14\u0000years with the age range of 20-45 years. The incidence of hysterectomy increased from 0.34/1000\u0000during 2009-2015 to 0.71/1000 deliveries in 2015-2022, with an overall incidence of 0.53 per 1000\u0000deliveries during 14 years. The results indicated that the mean rate of hysterectomy (0.95% CI) increased\u0000significantly by 0.059 yearly, and by adjusting other variables, the history of CS (0.95% CI)\u0000and placenta accreta previa significantly increased the hysterectomy mean rate by 0.291 (0.053-\u00000.529) and 0.284 (0.074-0.494), respectively.\u0000\u0000\u0000\u0000The mean rate of hysterectomy represented an annual increase, especially during the\u0000last 7 years. In summary, the main reason can be the history of CS that leads to placental disorders\u0000and, thus, hysterectomy.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140967762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-10DOI: 10.2174/0115734048280294240429115337
S. Hashemi, Farrokh Modarresi, A. Esmailzadeh, Nazanin Zeinab Sheikhsofla
Cervical cancer is reported as one of the most prevalent malignancies worldwide in women. There is a substantial connection between cervical diseases and infection with Human Papillomavirus (HPV), especially Types 16 and 18 of HPV. This study aimed to assess the HPV genotype distribution to determine its most common type at a referral hospital in Iran. This cross-sectional study was conducted on 400 women with positive HPV result tests who visited the gynecologic oncology clinic of Baqiyatallah Hospital from 2017-2021. The average age of subjects was 37.46±9.75 years (range=19-74). About 167 (41.8%) of the patients were between 25 to 35 years. The analysis showed that 137 (34.2%) patients had only low-risk (LR) typing, 129 (32.2%) patients had only high-risk (HR) typing, and 134 (33.5%) patients had both HR and LR typing. The most frequent LR HPV types were HPV 6 (18.5%) and 11 (17%), and the most frequent HR HPV types were HPV-16 (14.7%), 52 (8.2%), 18, and 31 (6.5%). This study showed that the most frequent age category in both low- and HR HPVpositive women is the age 25 to 35 years. The second most common HR-HPV subtypes included HPV-52, not HPV-18, which indicates variations in HR-HPV subtypes in different populations and races and warrants further research.
{"title":"Human Papillomavirus Genotype Distribution in a Hospital-based\u0000Single-Center Study","authors":"S. Hashemi, Farrokh Modarresi, A. Esmailzadeh, Nazanin Zeinab Sheikhsofla","doi":"10.2174/0115734048280294240429115337","DOIUrl":"https://doi.org/10.2174/0115734048280294240429115337","url":null,"abstract":"\u0000\u0000Cervical cancer is reported as one of the most prevalent malignancies\u0000worldwide in women. There is a substantial connection between cervical diseases and infection\u0000with Human Papillomavirus (HPV), especially Types 16 and 18 of HPV.\u0000\u0000\u0000\u0000This study aimed to assess the HPV genotype distribution to determine its most common\u0000type at a referral hospital in Iran.\u0000\u0000\u0000\u0000This cross-sectional study was conducted on 400 women with positive HPV result tests\u0000who visited the gynecologic oncology clinic of Baqiyatallah Hospital from 2017-2021.\u0000\u0000\u0000\u0000The average age of subjects was 37.46±9.75 years (range=19-74). About 167 (41.8%) of\u0000the patients were between 25 to 35 years. The analysis showed that 137 (34.2%) patients had only\u0000low-risk (LR) typing, 129 (32.2%) patients had only high-risk (HR) typing, and 134 (33.5%) patients had both HR and LR typing. The most frequent LR HPV types were HPV 6 (18.5%) and 11\u0000(17%), and the most frequent HR HPV types were HPV-16 (14.7%), 52 (8.2%), 18, and 31 (6.5%).\u0000\u0000\u0000\u0000This study showed that the most frequent age category in both low- and HR HPVpositive women is the age 25 to 35 years. The second most common HR-HPV subtypes included\u0000HPV-52, not HPV-18, which indicates variations in HR-HPV subtypes in different populations and\u0000races and warrants further research.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140993409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-09DOI: 10.2174/0115734048283699240429110405
Olubukola E. Abiodun-Ojo, Cecilia B. Bello, Laofe O. Ogundipe
Approximately 50% of pregnant women globally suffer from pregnancy-related anaemia, which is a serious issue for reproductive health and can lead to a number of complications, including low birth weights, premature deliveries, foetal deformities, and feto-maternal mortality. This study aimed to evaluate the suggested strategies to prevent anaemia in pregnancy through a 5-year scoping review (November, 2017 to November, 2022). A comprehensive list of keyword combinations linked to anemia prevention in pregnancy and pertinent approaches to inform the search strategy were evaluated. Significant events, including pregnancy and anemia, were cross-referenced with the frequency and variability of terms across time. Literature from Pubmed (MEDLINE), Google Scholar, PLOS One, and Cochrane database were reviewed. Evidence-based preventative therapy options for iron deficiency anaemia in pregnancy include prophylactic iron supplementation, food fortification with iron and folate, and health education. There is a wealth of research on the effects of these therapies on the occurrence of anaemia during pregnancy. However, these prospects are endangered by several variables, such as inadequate health facilities, low maternal health literacy, low utilisation of maternal health care in developing countries, a dearth of resources for health education, and lack of a government policy that prevents anaemia during pregnancy. If the highlighted challenges are appropriately addressed through the provision of health education material, the effectiveness of anaemia prevention in pregnancy could be sustained.
{"title":"Prevention of Anaemia in Pregnancy: A Five-Year Scoping Review","authors":"Olubukola E. Abiodun-Ojo, Cecilia B. Bello, Laofe O. Ogundipe","doi":"10.2174/0115734048283699240429110405","DOIUrl":"https://doi.org/10.2174/0115734048283699240429110405","url":null,"abstract":"\u0000\u0000Approximately 50% of pregnant women globally suffer from pregnancy-related\u0000anaemia, which is a serious issue for reproductive health and can lead to a number of complications, including low birth weights, premature deliveries, foetal deformities, and feto-maternal\u0000mortality.\u0000\u0000\u0000\u0000This study aimed to evaluate the suggested strategies to prevent anaemia in pregnancy\u0000through a 5-year scoping review (November, 2017 to November, 2022).\u0000\u0000\u0000\u0000A comprehensive list of keyword combinations linked to anemia prevention in pregnancy and pertinent approaches to inform the search strategy were evaluated. Significant\u0000events, including pregnancy and anemia, were cross-referenced with the frequency and variability of terms across time. Literature from Pubmed (MEDLINE), Google Scholar, PLOS One,\u0000and Cochrane database were reviewed.\u0000\u0000\u0000\u0000Evidence-based preventative therapy options for iron deficiency anaemia in pregnancy\u0000include prophylactic iron supplementation, food fortification with iron and folate, and health\u0000education. There is a wealth of research on the effects of these therapies on the occurrence of\u0000anaemia during pregnancy. However, these prospects are endangered by several variables, such\u0000as inadequate health facilities, low maternal health literacy, low utilisation of maternal health\u0000care in developing countries, a dearth of resources for health education, and lack of a government policy that prevents anaemia during pregnancy.\u0000\u0000\u0000\u0000If the highlighted challenges are appropriately addressed through the provision of\u0000health education material, the effectiveness of anaemia prevention in pregnancy could be sustained.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140995196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.2174/157340482003240213150542
John Yeh
{"title":"Breast Cancer and Women’s Health Physicians: Implications for New\u0000Approaches to Diagnosis and Treatment","authors":"John Yeh","doi":"10.2174/157340482003240213150542","DOIUrl":"https://doi.org/10.2174/157340482003240213150542","url":null,"abstract":"<jats:sec>\u0000<jats:title />\u0000<jats:p />\u0000</jats:sec>","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141057788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.2174/1573404820666230407114456
F. Moegni, Adri Dwi Anggayana, Seno Adjie, S. Hakim, T. Priyatini
Stress urinary incontinence (SUI) and pelvic organ prolapse (POP) would develop simultaneously because of the same etiopathogenesis of pelvic floor weakness. Some studies have said the association between SUI symptoms may be determined by the degree of anterior compartment prolapse. Then some incidences of occult SUI could also mask the symptom of SUI in the severe stage of POP. A total of 32 women diagnosed with POP and SUI from the urogynecology clinic were included in a cross-sectional study between 2019 and 2020. The degree of anterior compartment prolapse was measured using the POP-Q system (Ba point), while SUI's severity was measured using a 1- hour pad test in grams. The correlation between the severity of SUI (with the occurrence of occult SUI) and the anterior compartment prolapse was analyzed. No correlation was observed between the degree of anterior compartment prolapse and SUI degree (r = 0.240, p = 0.182). Occult SUI was found in only 5/24 (20.8%) grade III and IV anterior compartment prolapse cases. SUI symptom was not determined by the severity of anterior compartment prolapse. The prevalence of occult SUI in severe POP was also low.
压力性尿失禁（SUI）和盆腔器官脱垂（POP）会同时发生，因为它们的病因相同，都是盆底肌无力。一些研究表明，SUI 症状之间的关联可能取决于前房脱垂的程度。一项横断面研究共纳入了 32 名在 2019 年至 2020 年期间从泌尿妇科门诊诊断出患有 POP 和 SUI 的女性。研究使用 POP-Q 系统（Ba 点）测量前房脱垂的程度，而 SUI 的严重程度则使用以克为单位的 1 小时垫测试来测量。分析了 SUI 严重程度（包括隐性 SUI 的发生）与前室脱垂之间的相关性，未发现前室脱垂程度与 SUI 程度之间存在相关性（r = 0.240，p = 0.182）。仅在 5/24 例（20.8%）III 级和 IV 级前房脱垂病例中发现了隐匿性 SUI。在重度 POP 中，隐匿性 SUI 的发生率也很低。
{"title":"Is Stress Urinary Incontinence Symptom Determined by the Severity of\u0000Anterior Compartment Prolapse?","authors":"F. Moegni, Adri Dwi Anggayana, Seno Adjie, S. Hakim, T. Priyatini","doi":"10.2174/1573404820666230407114456","DOIUrl":"https://doi.org/10.2174/1573404820666230407114456","url":null,"abstract":"\u0000\u0000Stress urinary incontinence (SUI) and pelvic organ prolapse (POP) would develop\u0000simultaneously because of the same etiopathogenesis of pelvic floor weakness. Some studies\u0000have said the association between SUI symptoms may be determined by the degree of anterior compartment\u0000prolapse. Then some incidences of occult SUI could also mask the symptom of SUI in the\u0000severe stage of POP.\u0000\u0000\u0000\u0000A total of 32 women diagnosed with POP and SUI from the urogynecology clinic were included\u0000in a cross-sectional study between 2019 and 2020. The degree of anterior compartment prolapse\u0000was measured using the POP-Q system (Ba point), while SUI's severity was measured using a 1-\u0000hour pad test in grams. The correlation between the severity of SUI (with the occurrence of occult\u0000SUI) and the anterior compartment prolapse was analyzed.\u0000\u0000\u0000\u0000No correlation was observed between the degree of anterior compartment prolapse and SUI\u0000degree (r = 0.240, p = 0.182). Occult SUI was found in only 5/24 (20.8%) grade III and IV anterior\u0000compartment prolapse cases.\u0000\u0000\u0000\u0000SUI symptom was not determined by the severity of anterior compartment prolapse. The\u0000prevalence of occult SUI in severe POP was also low.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141036501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-20DOI: 10.2174/0115734048299563240318061151
Naina Kumar, I. Pradeep, M. Mangla, Annapurna Srirambhatla
Ovarian cancers are the third most common gynecological and 8th most common cancer in women, associated with high mortality rates globally. A 60-year-old postmenopausal woman presented to the Gynecological outpatient department with complaints of pain in the abdomen for 2-3 months and loss of appetite with weight loss for 1-2 months. She was diagnosed as a case of uterine leiomyosarcoma or left adnexal mass on ultrasound and MRI. Intra-operatively, she was diagnosed with a unilateral left ovarian malignant mass, predominantly solid in consistency with metastasis to the left fallopian tube, uterus, cervical stroma, and omentum. The right ovary and tube were healthy. On histopathological examination, the final diagnosis of primary mucinous ovarian carcinoma was made. The patient tolerated staging laparotomy (total abdominal hysterectomy with bilateral salpingo-oophorectomy and infracolic omentectomy) well and was started on six cycles of adjuvant chemotherapy with Paclitaxel and Carboplatin injections along with Bevacizumab. Primary mucinous ovarian carcinomas are rare and distinct subtypes of epithelial ovarian carcinomas. Due to their strong resemblance to other ovarian tumors and leiomyosarcoma, their diagnosis becomes challenging. Hence, it is crucial to consider leiomyosarcomas in the differential diagnosis of ovarian masses, especially in postmenopausal women.
{"title":"A Complex Case: Solid Unilateral Ovarian Mucinous Carcinoma\u0000Masquerading as Leiomyosarcoma in Postmenopausal Women","authors":"Naina Kumar, I. Pradeep, M. Mangla, Annapurna Srirambhatla","doi":"10.2174/0115734048299563240318061151","DOIUrl":"https://doi.org/10.2174/0115734048299563240318061151","url":null,"abstract":"\u0000\u0000Ovarian cancers are the third most common gynecological and 8th most\u0000common cancer in women, associated with high mortality rates globally.\u0000\u0000\u0000\u0000A 60-year-old postmenopausal woman presented to the Gynecological outpatient\u0000department with complaints of pain in the abdomen for 2-3 months and loss of appetite with\u0000weight loss for 1-2 months. She was diagnosed as a case of uterine leiomyosarcoma or left adnexal\u0000mass on ultrasound and MRI. Intra-operatively, she was diagnosed with a unilateral left ovarian malignant\u0000mass, predominantly solid in consistency with metastasis to the left fallopian tube, uterus,\u0000cervical stroma, and omentum. The right ovary and tube were healthy. On histopathological examination,\u0000the final diagnosis of primary mucinous ovarian carcinoma was made. The patient tolerated\u0000staging laparotomy (total abdominal hysterectomy with bilateral salpingo-oophorectomy and infracolic\u0000omentectomy) well and was started on six cycles of adjuvant chemotherapy with Paclitaxel\u0000and Carboplatin injections along with Bevacizumab.\u0000\u0000\u0000\u0000Primary mucinous ovarian carcinomas are rare and distinct subtypes of epithelial ovarian\u0000carcinomas. Due to their strong resemblance to other ovarian tumors and leiomyosarcoma, their\u0000diagnosis becomes challenging. Hence, it is crucial to consider leiomyosarcomas in the differential\u0000diagnosis of ovarian masses, especially in postmenopausal women.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140224618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-15DOI: 10.2174/0115734048285845240313085858
J.M. Seno Adjie, Janice Priscilla, Fahira Nada Safira
The incidence of challenging delivering experiences varies among societies and is impacted by various factors. The primary goal of this review was to assess the effect of supportive interventions pre- and during delivery on the likelihood of a positive childbirth experience. This study reviewed articles related to childbirth experience in international databases, such as PubMed, Cochrane, and ScienceDirect. A total of 1433 articles were found using the PRISMA guideline. Review research emphasized the supporting interventions during labor and women's subjective experience. Quality assessment was conducted using the modified Jadad scale. Overall, fifteen studies passed the eligibility criteria. The effective approaches to develop a favorable understanding of the whole birthing process encompassed the following supportive interventions: yoga exercise during pregnancy, antenatal hypnosis program, continuous supportive care during labor, family companion during labor, massage during labor, therapeutic touch program, acupressure during labor, birth ball exercise during labor, warm showers during the first stage, and dancing with music during the active phase of labor. Various supportive interventions related to childbirth may reduce pain and anxiety, build confidence, encourage, and serve as valuable psychosocial interventions for childbirth. Becoming a mother is not a frequent occurrence for all women, contributing to an overall experience in childbirth. Our study recommends interventions, such as yoga exercises during pregnancy, an antenatal hypnosis program, continuous supportive care during labor, a family companion during labor, massage during labor, a therapeutic touch program, acupressure during labor, birth ball exercise during labor, warm showers during the first stage, and dancing with music during the active phase of labor.
{"title":"The Childbirth Experience: A Systematic Review on Prenatal and Intrapartum Supportive Interventions","authors":"J.M. Seno Adjie, Janice Priscilla, Fahira Nada Safira","doi":"10.2174/0115734048285845240313085858","DOIUrl":"https://doi.org/10.2174/0115734048285845240313085858","url":null,"abstract":"\u0000\u0000The incidence of challenging delivering experiences varies among societies\u0000and is impacted by various factors. The primary goal of this review was to assess the effect of\u0000supportive interventions pre- and during delivery on the likelihood of a positive childbirth experience.\u0000\u0000\u0000\u0000This study reviewed articles related to childbirth experience in international databases,\u0000such as PubMed, Cochrane, and ScienceDirect. A total of 1433 articles were found using the\u0000PRISMA guideline. Review research emphasized the supporting interventions during labor and\u0000women's subjective experience. Quality assessment was conducted using the modified Jadad scale.\u0000\u0000\u0000\u0000Overall, fifteen studies passed the eligibility criteria. The effective approaches to develop a\u0000favorable understanding of the whole birthing process encompassed the following supportive interventions:\u0000yoga exercise during pregnancy, antenatal hypnosis program, continuous supportive care\u0000during labor, family companion during labor, massage during labor, therapeutic touch program, acupressure\u0000during labor, birth ball exercise during labor, warm showers during the first stage, and\u0000dancing with music during the active phase of labor.\u0000\u0000\u0000\u0000Various supportive interventions related to childbirth may reduce pain and anxiety,\u0000build confidence, encourage, and serve as valuable psychosocial interventions for childbirth. Becoming\u0000a mother is not a frequent occurrence for all women, contributing to an overall experience\u0000in childbirth. Our study recommends interventions, such as yoga exercises during pregnancy, an antenatal\u0000hypnosis program, continuous supportive care during labor, a family companion during labor,\u0000massage during labor, a therapeutic touch program, acupressure during labor, birth ball exercise\u0000during labor, warm showers during the first stage, and dancing with music during the active\u0000phase of labor.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140238033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-11DOI: 10.2174/0115734048265172231018071749
Rizwana Bee, Mohammad Ahmad, S. Verma, Ritesh kumar Tiwari
This aim of the study was to gather information for use in the present and future management of the adenomyosis condition. Adenomyosis is a benign gynecological condition that needs to be managed for the rest of one's life with either medication or surgical treatment. It is also associated with abnormal uterine bleeding, dysmenorrhea, dyspareunia, and infertility. The choice a woman makes will be influenced by her age, reproductive status, and clinical indicators. The primary goals of this study were to gain knowledge on adenomyosis and to review potential treatment possibilities. According to this review, adenomyosis can be treated in a number of ways, including through medical attention utilizing least-invasive techniques a surgical operation that is performed with minimally invasive techniques. Focused ultrasound with high intensity (HIFU) for hysteroscopic ablation and resection Embolishing the uterine artery (UAE). Adenomyosis is a benign gynecological illness that necessitates a lifelong care strategy by medication or surgical therapy and is accompanied by abnormal uterine hemorrhage, dysmenorrhea, dyspareunia, and infertility. The option a woman chooses will depend on her age, reproductive status, and clinical signs. Since there is currently no medication approved for the treatment of adenomyosis, the present review will focus on existing and future medical procedures for the condition. The uterus is impacted by the medical condition adenomyosis. It happens when the endometrial tissue that normally lines the uterus invades the myometrium, the uterine muscle wall. Although this illness is benign, some people may experience substantial pain and discomfort as a result of it. It is more typically detected in those who have had children and is most frequently diagnosed in people between the ages of 30 and 50. Treatment options depend on the severity of symptoms and the individual's specific situation. Treatment approaches may include Pain Management, Hormonal Therapy, Surgical Interventions, Surgical Interventions and Lifestyle Changes. Several uterine-sparing therapeutic alternatives are currently available, each with unique risks and benefits, such as medication, hysteroscopic resection or ablation, conservative surgical methods, and high-intensity focused ultrasound. Uterine artery embolization, a practical, secure, and cost-effective method for treating uterine fibroids, has recently grown in popularity as a treatment for uterine adenomyosis.
{"title":"Current Trends and Future Strategies on Diagnosis and Management of\u0000Adenomyosis: An Updated Review","authors":"Rizwana Bee, Mohammad Ahmad, S. Verma, Ritesh kumar Tiwari","doi":"10.2174/0115734048265172231018071749","DOIUrl":"https://doi.org/10.2174/0115734048265172231018071749","url":null,"abstract":"\u0000\u0000This aim of the study was to gather information for use in the present and future management\u0000of the adenomyosis condition. Adenomyosis is a benign gynecological condition that\u0000needs to be managed for the rest of one's life with either medication or surgical treatment. It is also\u0000associated with abnormal uterine bleeding, dysmenorrhea, dyspareunia, and infertility. The\u0000choice a woman makes will be influenced by her age, reproductive status, and clinical indicators.\u0000The primary goals of this study were to gain knowledge on adenomyosis and to review potential\u0000treatment possibilities. According to this review, adenomyosis can be treated in a number of ways,\u0000including through medical attention utilizing least-invasive techniques a surgical operation that is\u0000performed with minimally invasive techniques. Focused ultrasound with high intensity (HIFU) for\u0000hysteroscopic ablation and resection Embolishing the uterine artery (UAE). Adenomyosis is a benign\u0000gynecological illness that necessitates a lifelong care strategy by medication or surgical therapy\u0000and is accompanied by abnormal uterine hemorrhage, dysmenorrhea, dyspareunia, and infertility.\u0000The option a woman chooses will depend on her age, reproductive status, and clinical signs.\u0000Since there is currently no medication approved for the treatment of adenomyosis, the present review\u0000will focus on existing and future medical procedures for the condition. The uterus is impacted\u0000by the medical condition adenomyosis. It happens when the endometrial tissue that normally\u0000lines the uterus invades the myometrium, the uterine muscle wall. Although this illness is benign,\u0000some people may experience substantial pain and discomfort as a result of it. It is more typically\u0000detected in those who have had children and is most frequently diagnosed in people between the\u0000ages of 30 and 50. Treatment options depend on the severity of symptoms and the individual's specific\u0000situation. Treatment approaches may include Pain Management, Hormonal Therapy, Surgical\u0000Interventions, Surgical Interventions and Lifestyle Changes. Several uterine-sparing therapeutic alternatives\u0000are currently available, each with unique risks and benefits, such as medication, hysteroscopic\u0000resection or ablation, conservative surgical methods, and high-intensity focused ultrasound.\u0000Uterine artery embolization, a practical, secure, and cost-effective method for treating uterine fibroids,\u0000has recently grown in popularity as a treatment for uterine adenomyosis.\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140253406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-07DOI: 10.2174/0115734048285132240229084803
J.M. Seno Adjie, Teresa Catalina R., Janice Priscilla
Negative childbirth experiences impact the well-being of women and their families. With rising induction of labor (IOL) rates and the inconsistent evidence regarding its impact on childbirth experiences, we conducted a systematic review and meta-analysis to estimate the overall effect of IOL versus expectant management on women’s childbirth experiences, defined as a woman’s self-assessment of her lasting memories of the childbirth event. We searched databases (PubMed, Embase, Cochrane Library, Science Direct, ProQuest and EBSCO) for RCTs and observational studies from 1970 to September 2023. Inclusion criteria covered women aged 19 and older with live, singleton, cephalic pregnancies at 37 0/7 until 41 6/7 weeks gestation. Quality was assessed using the Jadad and Newcastle-Ottawa Scales. RevMan 5.4 software and random-effects meta-analysis were used, adhering to PRISMA guidelines. Of the 1.467 screened articles, we included nine studies from five European countries. Six studies (2.376 women) used the Childbirth Experience Questionnaire (CEQ). Overall CEQ scores showed no significant IOL vs. expectant management differences (MD = 0.01 [95% CI -0.06, 0.08]; p=0.78; I2 = 65%). Subgroup analyses favored IOL in RCTs (MD = 0.07 [95% CI 0.02, 0.13]; p=0.006; I2 = 0%) and studies with ≥500 participants (MD = 0.09 [95% CI 0.02, 0.15]; p=0.006; I2 = 0%). Conversely, four studies (48.324 women) using the Childbirth Experience Visual Analogue Scale (VAS) favored expectant management (OR = 0.73 [95% CI 0.63, 0.85]; p<0.001; I2 = 86%). VAS assessments suggest a more positive childbirth experience with the expectant management group. Improvements in the IOL process, transfer to delivery, and pain relief administration may benefit the IOL group. In contrast, the overall CEQ scores did not significantly differ between groups. Clinical practice should consider individualized approaches that align with patient needs and medical contexts. Limitations, such as variability in study quality and data heterogeneity, should be acknowledged. CRD42023464153
{"title":"Exploring Women’s Childbirth Experiences in Labor Induction versus Expectant Management: A Systematic Review and Meta-analysis","authors":"J.M. Seno Adjie, Teresa Catalina R., Janice Priscilla","doi":"10.2174/0115734048285132240229084803","DOIUrl":"https://doi.org/10.2174/0115734048285132240229084803","url":null,"abstract":"\u0000\u0000Negative childbirth experiences impact the well-being of women and their\u0000families. With rising induction of labor (IOL) rates and the inconsistent evidence regarding its\u0000impact on childbirth experiences, we conducted a systematic review and meta-analysis to estimate\u0000the overall effect of IOL versus expectant management on women’s childbirth experiences, defined\u0000as a woman’s self-assessment of her lasting memories of the childbirth event.\u0000\u0000\u0000\u0000We searched databases (PubMed, Embase, Cochrane Library, Science Direct, ProQuest\u0000and EBSCO) for RCTs and observational studies from 1970 to September 2023. Inclusion criteria\u0000covered women aged 19 and older with live, singleton, cephalic pregnancies at 37 0/7 until 41 6/7\u0000weeks gestation. Quality was assessed using the Jadad and Newcastle-Ottawa Scales. RevMan 5.4\u0000software and random-effects meta-analysis were used, adhering to PRISMA guidelines.\u0000\u0000\u0000\u0000Of the 1.467 screened articles, we included nine studies from five European countries. Six\u0000studies (2.376 women) used the Childbirth Experience Questionnaire (CEQ). Overall CEQ scores\u0000showed no significant IOL vs. expectant management differences (MD = 0.01 [95% CI -0.06, 0.08];\u0000p=0.78; I2 = 65%). Subgroup analyses favored IOL in RCTs (MD = 0.07 [95% CI 0.02, 0.13];\u0000p=0.006; I2 = 0%) and studies with ≥500 participants (MD = 0.09 [95% CI 0.02, 0.15]; p=0.006; I2\u0000= 0%). Conversely, four studies (48.324 women) using the Childbirth Experience Visual Analogue\u0000Scale (VAS) favored expectant management (OR = 0.73 [95% CI 0.63, 0.85]; p<0.001; I2 = 86%).\u0000\u0000\u0000\u0000VAS assessments suggest a more positive childbirth experience with the expectant\u0000management group. Improvements in the IOL process, transfer to delivery, and pain relief\u0000administration may benefit the IOL group. In contrast, the overall CEQ scores did not significantly\u0000differ between groups. Clinical practice should consider individualized approaches that align with\u0000patient needs and medical contexts. Limitations, such as variability in study quality and data\u0000heterogeneity, should be acknowledged.\u0000\u0000\u0000\u0000CRD42023464153\u0000","PeriodicalId":11030,"journal":{"name":"Current Women s Health Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140258275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：